Cambridge Cognition Holdings plc’s non-executive chair, Nick Rodgers, has executed a purchase of 19,000 ordinary shares in the company, priced at 27.4 pence per share, according to market data. The transaction occurred on September 18, elevating Rodgers’ total holdings to 98,892 shares, which represent approximately 0.18% of the company’s issued share capital. Cambridge Cognition specializes in developing digital cognitive assessments, leveraging platforms such as CANTAB and Winterlight to support scientific research, pharmaceutical drug development, and patient care. The company operates on the London Stock Exchange under the AIM market listing (ticker: COG).
Cambridge Cognition Chair Buys 19,000 Shares at 27.4p
Non-executive chair Nick Rodgers acquires 19,000 shares in Cambridge Cognition Holdings plc at a price of 27.4p per share, raising his stake to 0.18% of issued share capital.
PA
Priya Anand · Equities & Earnings Desk · 26 Sept 2026 · 19:17 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
PA
Written by
Priya Anand
Equities & Earnings Desk
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
